An Ad Blitz That Really Worked?

Biotech Industry Gets a Big Win on Biologics

By Kate Ackley
Roll Call Staff

July 15, 2009, 12 a.m.

A highly targeted lobbying and advertising campaign by the biotechnology and pharmaceutical industries paid off this week when a Senate panel writing health care reform legislation swung their way on the issue of biologic drugs.

Most Popular
Most E-Mailed

The 50 Richest Members of Congress
Murtha Dies at 77
Top House Republicans Set Ground Rules for Health Care Talks

New York: Draft Kudlow for Senate Committee Growing
Road to 2012 Is Paved With PAC Donations
Snow Confuses Congress’ Plans

Committee
Insider
Policy
Briefings
Guest
Observers
10 Staffers
to Know

Cardin: U.S. Needs to Keep Pace Developing Energy Technology

Feb. 8, 12 a.m.

Today, too many Americans are out of work. Today, we will send $1 billion overseas to satisfy our appetite for foreign oil, while the Chinese will continue their massive investment in clean energy technology. Today, our nation faces an economic crisis, an energy crisis and a global climate crisis. Read Full Article